ACCURAY INCORPORATED Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease)
ACCURAY INCORPORATED (ARAY) reported Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $0 for the 12-month period ending 2022-06-30, per its 10-K filed 2022-08-17.
Discontinued › Notes › and Others
us-gaap:FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease · last filed 2022-08-17
- ACCURAY INCORPORATED financing receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2022-06-30 was -$900.00K, a 200.00% decline year-over-year.
- ACCURAY INCORPORATED financing receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- ACCURAY INCORPORATED financing receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2021-12-31 was $0.00.
- ACCURAY INCORPORATED financing receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2021-09-30 was $900.00K.
- ACCURAY INCORPORATED financing receivable, allowance for credit loss, period increase (decrease) for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- ACCURAY INCORPORATED financing receivable, allowance for credit loss, period increase (decrease) for fiscal 2021 was $3.40M, a 325.00% increase from fiscal 2020.
- ACCURAY INCORPORATED financing receivable, allowance for credit loss, period increase (decrease) for fiscal 2020 was $800.00K, a 77.78% decline from fiscal 2019.
- ACCURAY INCORPORATED financing receivable, allowance for credit loss, period increase (decrease) for fiscal 2019 was $3.60M.
| Period end | Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month | Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 month | Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9 month | Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-17 | -$900.00K derived: sum of 2 quarters · filed 2022-08-17 | -$900.00K derived: sum of 3 quarters · filed 2022-08-17 | $0.00 10-K · filed 2022-08-17 |
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-29 | $0.00 derived: sum of 2 quarters · filed 2022-04-29 | $900.00K 10-Q · filed 2022-04-29 | $1.80M derived: sum of 4 quarters · filed 2022-04-29 |
| 2021-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-28 | $900.00K 10-Q · filed 2022-01-28 | $1.80M derived: sum of 3 quarters · filed 2022-01-28 | $1.99M derived: sum of 4 quarters · filed 2022-01-28 |
| 2021-09-30 | $900.00K 10-Q · filed 2021-11-04 | $1.80M derived: sum of 2 quarters · filed 2021-11-04 | $1.99M derived: sum of 3 quarters · filed 2021-11-04 | |
| 2021-06-30 | $900.00K 10-Q · filed 2021-11-04 | $1.09M derived: sum of 2 quarters · filed 2021-11-04 | $3.40M 10-K · filed 2022-08-17 | |
| 2021-03-31 | $189.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-30 | $200.00K 10-Q · filed 2021-04-30 | ||
| 2020-12-31 | $11.00K 10-Q · filed 2021-02-01 | |||
| 2020-06-30 | $800.00K 10-K · filed 2021-08-17 | |||
| 2019-06-30 | $3.60M 10-K · filed 2020-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |